Your about to leave the site and are being redirected to another site. Would you like to leave this site?





For previously treated patients with advanced metastatic bladder cancer (urothelial carcinoma)

For patients with metastatic Merkel cell carcinoma (mMCC)


    BAVENCIO (avelumab) is a prescription medicine used to treat:

  • A type of skin cancer called Merkel cell carcinoma. BAVENCIO may be used when your skin cancer has spread
  • A type of cancer in the bladder or urinary tract called urothelial cancer. BAVENCIO may be used when your cancer has spread or cannot be removed by surgery (advanced urothelial cancer), and you have received chemotherapy that contains a platinum-containing drug and it did not work or is no longer working

The approval of BAVENCIO in these patients was based on studies that measured response rate and duration of response. There are ongoing studies to confirm clinical benefit.

It is not known if BAVENCIO is safe and effective in children under the age of 12.

Visit to learn about patient access and reimbursement support for BAVENCIO—or call 844-8COVER1